Ascendis Pharma (ASND) PT Lowered to $180 at Morgan Stanley

March 7, 2022 3:26 AM EST Send to a Friend
Morgan Stanley analyst David Lebowitz ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login